Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy as First-Line Treatment for Helicobacter pylori Infection: A Nationwide Randomized Trial in Korea

BACKGROUND/AIMS: This nationwide, multicenter prospective randomized controlled trial aimed to compare the efficacy and safety of 10-day concomitant therapy (CT) and 10-day sequential therapy (ST) with 7-day clarithromycin-containing triple therapy (TT) as first-line treatment for Helicobacter pylor...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Gut Liver
Main Authors: Kim, Beom Jin, Lee, Hyuk, Lee, Yong Chan, Jeon, Seong Woo, Kim, Gwang Ha, Kim, Hyun-Soo, Sung, Jae Kyu, Lee, Dong Ho, Kim, Heung Up, Park, Moo In, Choi, Il Ju, Yoon, Soon Man, Kim, Sang Wook, Baik, Gwang Ho, Lee, Ju Yup, Kim, Jin Il, Kim, Sang Gyun, Kim, Jayoun, Lee, Joongyup, Kim, Jae Gyu, Kim, Jae J.
Formato: Artigo
Idioma:Inglês
Publicado: Editorial Office of Gut and Liver 2019
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6743805/
https://ncbi.nlm.nih.gov/pubmed/31505907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl19136
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares